SV Health Investors, LLC - Q1 2015 holdings

$303 Million is the total value of SV Health Investors, LLC's 5 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 33.3% .

 Value Shares↓ Weighting
OCUL  OCULAR THERAPEUTIX INC$108,570,000
+78.5%
2,585,6070.0%35.88%
+18.2%
OPHT SellOPHTHOTECH CORP$95,533,000
-18.8%
2,053,143
-21.7%
31.57%
-46.2%
ENTL NewENTELLUS MED INC$76,421,0003,489,533
+100.0%
25.25%
TRXC  TRANSENTERIX INC$22,112,000
+0.7%
7,546,6920.0%7.31%
-33.3%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • SVLSF IV, LLC #1
  • SV Life Sciences Fund IV (GP), L.P. #2
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSENTERIX, INC.27Q4 202024.0%
OCULAR THERAPEUTIX, INC.24Q2 202035.9%
KALVISTA PHARMACEUTICALS INC17Q4 202031.0%
DECIPHERA PHARMACEUTICALS INC17Q3 202131.0%
CATABASIS PHARMACEUTICALS, INC.15Q4 201818.2%
X4 PHARMACEUTICALS INC15Q3 20223.2%
BICYCLE THERAPEUTICS PLC14Q3 202265.4%
SUTRO BIOPHARMA INC14Q4 202119.1%
ENTELLUS MED INC12Q4 201764.4%
AVROBIO INC12Q1 202141.6%

View SV Health Investors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-07
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-12
13F-HR2020-08-14

View SV Health Investors, LLC's complete filings history.

Compare quarters

Export SV Health Investors, LLC's holdings